Evaluation of the effectiveness of transobturator tape operation in the treatment of stress incontinence

Year 2023, Volume: 13 Issue: 1, 24 - 29, 31.01.2023

Ali Buhur , Necdet Öncü

https://doi.org/10.16899/jcm.1203481

Cited By: 1

Abstract

Abstract
Background/Aims:: In this study, In this study, we aimed to assess the effectiveness of Transobturator Tape Operation in the treatment of Stress İncontinence
Methods: We retrospectively evaluated 454 patients who had TOT operations due to stress urinary incontinence between January 1, 2017, and December 31, 2020, at the İstanbul Kanuni Traning and Research Hospital. The basic clinical characteristics of the participants were recorded. The number of daily peds, values of Q-type test and urinary retention, and scores of urogenital disorder inventory-6 and impact of incontinence inquiry form at the clinical evaluation perioperatively and 6 months after the operation. Data analysis of the study was done with the SPSS version 24.0 package program. Kolmogorov-Smirnov test was used for normality analysis. Wilcoxon test was used for the comparisons of preop and postop data. It was considered statistically significant when the P value was below 0.05
Results: The study was conducted on 454 patients aged 26-83 years with a mean age of 50.3±10 years. The overall complication rate was 15.9. The rate of those who recovered six months after the operation was 89.6%. The number of daily peds, values of Q-tip test and urinary retention, and scores of questionnaires were significantly reduced after surgery (p=0.001).
Conclusions: The TOT operation can be preferred in treating stress incontinence with acceptable success and outcome. The scales of questionnaires successfully determine patient satisfaction with surgical efficacy for SUI.

Keywords

: Stress urinary incontinence, transobturator tape operation, urogenital disorder inventory-6, the impact of incontinence inquiry

Stres İnkontinans tedavisinde trans obturator bant operasyonunun etkinliğinin değerlendirilmesi

Abstract

Amaç: Bu çalışmada, stres inkontinans tedavisinde transobturator bant operasyonunun etkinliğini değerlendirmeyi amaçladık.
Yöntemler: 1 Ocak 2017-31 Aralık 2020 tarihleri arasında İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi'nde stres üriner inkontinans nedeniyle TOT ameliyatı olan 454 hasta retrospektif olarak değerlendirildi. Katılımcıların temel klinik özellikleri kaydedildi. Operasyonun klinik değerlendirmesi perioperatif ve 6 ay sonra günlük ped sayısı, Q-tipi test ve idrar retansiyonu değerleri, ürogenital bozukluk envanteri-6 puanları ve inkontinans sorgulama formu ile yapıldı. Çalışmanın veri analizi SPSS versiyon 24.0 paket programı ile yapılmıştır. Normallik analizi için Kolmogorov-Smirnov testi kullanıldı. Ameliyat öncesi ve sonrası verilerin karşılaştırılmasında Wilcoxon testi kullanıldı. P değeri 0.05'in altında olduğunda istatistiksel olarak anlamlı kabul edildi.
Bulgular: Çalışma yaş ortalaması 50.3±10 yıl olan 26-83 yaş arası 454 hasta üzerinde yapıldı. Genel komplikasyon oranı 15.9 idi. Ameliyattan altı ay sonra iyileşenlerin oranı %89,6 idi. Ameliyattan sonra günlük ped sayısı, Q-tip testi ve idrar retansiyonu değerleri ve anket puanları önemli ölçüde azaldı (p=0,001).
Sonuçlar: Stres inkontinans tedavisinde TOT operasyonu kabul edilebilir başarı ve sonuçlarla tercih edilebilir. Anket ölçekleri, SUI için cerrahi etkinlik ile hasta memnuniyetini başarılı bir şekilde belirler.

Keywords

Stres üriner inkontinans, , transobturator bant operasyonu, ürogenital bozukluk envanteri-6, , inkontinans sorgulamasının etkisi

References

• 1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002;21(2):167–178.
• 2. Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary incontinence in women in four European countries. BJU Int. 2004;93(3):324–330.
• 3. Trowbridge ER, Hoover EF. Evaluation and Treatment of Urinary Incontinence in Women. Gastroenterol. Clin. North Am. 2022;51(1):157–175.
• 4. Nambiar AK, Arlandis S, Bø K et al. European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence. Eur. Urol. 2022.
• 5. Ulmsten U, Petros P. Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand. J. Urol. Nephrol. 1995;29(1):75–82.
• 6. Ulmsten U, Falconer C, Johnson P et al. A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int. Urogynecology J. 1998;9(4):210–213.
• 7. Ward KL, Hilton P. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am. J. Obstet. Gynecol. 2004;190(2):324–331.
• 8. Delorme E, Droupy S, de TAYRAC R, Delmas V. La bandelette trans-obturatrice (Uratape®). Un nouveau procédé mini-invasif de traitement de l’incontinence urinaire de la femme. Prog. En Urol. Paris 2003;13(4):656–659.
• 9. Costa P, Grise P, Droupy S et al. Surgical treatment of female stress urinary incontinence with a trans-obturator-tape (TOT®) Uratape®: Short term results of a prospective multicentric study. Eur. Urol. 2004;46(1):102–107.
• 10. Leone Roberti Maggiore U, Finazzi Agrò E, Soligo M et al. Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Int. Urogynecology J. 2017;28(8):1119–1130.
• 11. Skorupska K, Grzybowska ME, Kubik-Komar A, Rechberger T, Miotla P. Identification of the Urogenital Distress Inventory-6 and the Incontinence Impact Questionnaire-7 cutoff scores in urinary incontinent women. Health Qual. Life Outcomes 2021;19(1):1–6.
• 12. Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG Int. J. Obstet. Gynaecol. 2007;114(5):522–531.
• 13. Mangano E, Campagne-Loiseau S, Curinier S et al. Transobturator vaginal tape in 10 Steps. J. Minim. Invasive Gynecol. 2020;27(1):27–28.
• 14. Hägglund D, Olsson H, Leppert J. Urinary incontinence: an unexpected large problem among young females. Results from a population-based study. Fam. Pract. 1999;16(5):506–509.
• 15. Ford AA, Taylor V, Ogah J et al. Midurethral slings for treatment of stress urinary incontinence review. Neurourol. Urodyn. 2019;38:S70–S75.
• 16. CHAIKIN DC, Rosenthal J, Blaivas JG. Pubovaginal fascial sling for all types of stress urinary incontinence: long-term analysis. J. Urol. 1998;160(4):1312–1316.
• 17. Cubuk A, Yanaral F, Savun M et al. Modified autologous transobturator tape surgery—evaluation of short term results. Ginekol. Pol. 2020;91(2):51–56.
• 18. Deval B, Ferchaux J, Berry R et al. Objective and subjective cure rates after trans-obturator tape (OBTAPE®) treatment of female urinary incontinence. Eur. Urol. 2006;49(2):373–377.
• 19. Verbrugghe A, De Ridder D, Van der Aa F. A repeat mid-urethral sling as valuable treatment for persistent or recurrent stress urinary incontinence. Int. Urogynecology J. 2013;24(6):999–1004.
• 20. Bakali E, Buckley BS, Hilton P, Tincello DG. Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women. Cochrane Database Syst. Rev. 2013;(2).
• 21. FitzGerald MP, Kenton K, Shott S, Brubaker L. Responsiveness of quality of life measurements to change after reconstructive pelvic surgery. Am. J. Obstet. Gynecol. 2001;185(1):20–24.
• 22. Lo T-S, Wang AC, Horng S-G, Liang C-C, Soong Y-K. Ultrasonographic and urodynamic evaluation after tension free vagina tape procedure (TVT). Acta Obstet. Gynecol. Scand. 2001;80(1):65–65.
• 23. Zengin K, Kara M, Tanik S, Sertcelik MN, Eraslan A. Comparison of Transobturator Tape and Mini-Sling Tissue Fixation in Female Patients Who Had Stress Urinary Incontinence. Adv. Clin. Exp. Med. Off. Organ Wroclaw Med. Univ. 2015;24(5):851–855.
• 24. But I. Vaginal wall erosion after transobturator tape procedure. Int. Urogynecology J. 2005;16(6):506–508.
• 25. Kaelin-Gambirasio I, Jacob S, Boulvain M, Dubuisson J-B, Dällenbach P. Complications associated with transobturator sling procedures: analysis of 233 consecutive cases with a 27 months follow-up. BMC Womens Health 2009;9(1):1–7.
• 26. Dalpiaz O, Knopf HJ, Orth S et al. Mid-term complications after placement of the male adjustable suburethral sling: a single center experience. J. Urol. 2011;186(2):604–609.
• 27. Abdel-Fattah M, Ramsay I, Pringle S. Lower urinary tract injuries associated with transobturator tension free vaginal tape procedure: a large retrospective study. BJOG 2006;113(12):1377–1382.
• 28. Cholhan HJ, Hutchings TB, Rooney KE. Dyspareunia associated with paraurethral banding in the transobturator sling. Am. J. Obstet. Gynecol. 2010;202(5):481-e1.
• 29. Grise P, Droupy S, Saussine C et al. Transobturator tape sling for female stress incontinence with polypropylene tape and outside-in procedure: prospective study with 1 year of minimal follow-up and review of transobturator tape sling. Urology 2006;68(4):759–763.
• 30. Juma S, Brito CG. Transobturator tape (TOT): two years follow-up. Neurourol. Urodyn. Off. J. Int. Cont. Soc. 2007;26(1):37–41.
• 31. Barber MD, Gustilo-Ashby AM, Chen CCG et al. Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape. Am. J. Obstet. Gynecol. 2006;195(6):1820–1825.
• 32. Dobson A, Robert M, Swaby C, Murphy M, Birch C, Mainprize T, Ross S. Trans-obturator surgery for stress urinary incontinence: 1-year follow-up of a cohort of 52 women. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jan;18(1):27-32. DOI: 10.1007/s00192-006-0115-9.
• 33. Mellier G, Moore R, Jacquetin B. A meta-analysis of the intra-operative safety and effectiveness of the transobturator hammock seen in results of two prospective studies in 9 countries with 204 patients. ICS/IUGA Joint meeting. Paris 2004.